BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
236 results:

  • 1. Serine/threonine-protein kinase D2-mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression.
    Liu YQ; Xu YW; Zheng ZT; Li D; Hong CQ; Dai HQ; Wang JH; Chu LY; Liao LD; Zou HY; Li EM; Xie JJ; Fang WK
    J Pathol; 2024 May; 263(1):99-112. PubMed ID: 38411280
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Salivary gland carcinoma: Towards a more personalised approach.
    Rached L; Saleh K; Casiraghi O; Even C
    Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Global research on sinonasal inverted papilloma over the past two decades: a bibliometric analysis.
    Fan D; Zhu Y; Yang J; Hou J
    Acta Otorhinolaryngol Ital; 2024 Apr; 44(2):83-90. PubMed ID: 38165205
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Unveiling Therapeutic Targets for Esophageal cancer: A Comprehensive Review.
    Acharya R; Mahapatra A; Verma HK; Bhaskar LVKS
    Curr Oncol; 2023 Oct; 30(11):9542-9568. PubMed ID: 37999111
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Decoding the role of miRNAs in oral cancer pathogenesis: A focus on signaling pathways.
    Doghish AS; El-Husseiny AA; Khidr EG; Elrebehy MA; Elballal MS; Abdel-Reheim MA; Abdel Mageed SS; Zaki MB; Mohammed OA; Khaled R; El-Dakroury WA; Noureldin S; Moustafa YM; Mangoura SA; Gedawy EM; Abulsoud AI
    Pathol Res Pract; 2023 Dec; 252():154949. PubMed ID: 37992507
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of egfr/PI3K/AKT/mTOR pathway.
    Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X
    Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cardiorespiratory fitness and BMI measured in youth and 5-year mortality after site-specific cancer diagnoses in men-A population-based cohort study with register linkage.
    Onerup A; Mehlig K; Ekblom-Bak E; Lissner L; Börjesson M; Åberg M
    Cancer Med; 2023 Oct; 12(19):20000-20014. PubMed ID: 37732468
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
    Key S; Chia C; Hasan Z; Sundaresan P; Riffat F; Dwivedi RC
    Laryngoscope; 2024 Mar; 134(3):1042-1053. PubMed ID: 37610148
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans.
    Rebaudi F; De Rosa A; Greppi M; Pistilli R; Pucci R; Govoni FA; Iacoviello P; Broccolo F; Tomasello G; Pesce S; Laganà F; Bianchi B; Di Gaudio F; Rebaudi A; Marcenaro E
    Front Immunol; 2023; 14():1216107. PubMed ID: 37483588
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives.
    Lee JM; McNamee CJ; Toloza E; Negrao MV; Lin J; Shum E; Cummings AL; Kris MG; Sepesi B; Bara I; Kurtsikidze N; Schulze K; Ngiam C; Chaft JE
    J Thorac Oncol; 2023 Nov; 18(11):1458-1477. PubMed ID: 37451404
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
    Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
    Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Incidence, trends, and survival of oropharyngeal squamous cell cancer in Aotearoa New Zealand, 2006-2020.
    Win Myint TT; McIvor N; Douglas R; Tin Tin S; Elwood M
    Cancer Epidemiol; 2023 Aug; 85():102393. PubMed ID: 37267678
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preclinical evaluation of a novel egfr&c-Met bispecific near infrared probe for visualization of esophageal cancer and metastatic lymph nodes.
    Liang M; Wang L; Xiao Y; Yang M; Mei C; Zhang Y; Shan H; Li D
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2787-2801. PubMed ID: 37145165
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Simultaneous Detection of Two Extracellular Vesicle Subpopulations in Saliva Assisting Tumor T Staging of Oral Squamous Cell Carcinoma.
    Feng J; Xiao BL; Zhang LZ; Zhang YH; Tang M; Xu CM; Chen G; Zhang ZL
    Anal Chem; 2023 May; 95(19):7753-7760. PubMed ID: 37130010
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Analyses of single extracellular vesicles from non-small lung cancer cells to reveal effects of epidermal growth factor receptor inhibitor treatments.
    Stridfeldt F; Cavallaro S; Hååg P; Lewensohn R; Linnros J; Viktorsson K; Dev A
    Talanta; 2023 Jul; 259():124553. PubMed ID: 37084607
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Low-grade papillary Schneiderian carcinoma with TP53 mutation: a case report and review of the literature.
    Yuzawa S; Michizuka T; Kakisaka R; Ono Y; Hayashi M; Takahara M; Katada A; Mizukami Y; Tanino M
    Diagn Pathol; 2023 Apr; 18(1):44. PubMed ID: 37041626
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The molecular landscape of breast mucoepidermoid carcinoma.
    Venetis K; Sajjadi E; Ivanova M; Andaloro S; Pessina S; Zanetti C; Ranghiero A; Citelli G; Rossi C; Lucioni M; Malapelle U; Pagni F; Barberis M; Guerini-Rocco E; Viale G; Fusco N
    Cancer Med; 2023 May; 12(9):10725-10737. PubMed ID: 36916425
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with egfr L858R Mutation.
    Hou Z; Wu H; Luo N; Li S; Zhang X; Dong S; Zhu D; Zhang H; Tao R
    Oncologist; 2023 May; 28(5):449-452. PubMed ID: 36913260
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Exploring the robustness of DNA nanotubes framework for anticancer theranostics toward the 2D/3D clusters of hypopharyngeal respiratory tumor cells.
    Baig MMFA; Ma J; Gao X; Khan MA; Ali A; Farid A; Zia AW; Noreen S; Wu H
    Int J Biol Macromol; 2023 May; 236():123988. PubMed ID: 36907299
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Bioconjugation studies of an EGF-R targeting ligand on dendronized iron oxide nanoparticles to target head and neck cancer cells.
    Freis B; Ramírez MLÁ; Furgiuele S; Journe F; Cheignon C; Charbonnière LJ; Henoumont C; Kiefer C; Mertz D; Affolter-Zbaraszczuk C; Meyer F; Saussez S; Laurent S; Tasso M; Bégin-Colin S
    Int J Pharm; 2023 Mar; 635():122654. PubMed ID: 36720449
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.